Bg pattern

TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Zentiva Tranexamic Acid 500mg Film-Coated Tablets EFG

tranexamic acid

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack:

  1. What Zentiva Tranexamic Acid is and what it is used for
  2. What you need to know before you take Zentiva Tranexamic Acid
  3. How to take Zentiva Tranexamic Acid
  4. Possible side effects.
  5. Storage of Zentiva Tranexamic Acid.
  6. Contents of the pack and further information.

1. What Zentiva Tranexamic Acid is and what it is used for

Tranexamic acid belongs to a group of medicines called anti-fibrinolytic agents. These medicines are used to stop or reduce bleeding. In the event of bleeding, the body forms clots to stop it. In some people, these clots are broken down, which can cause excessive bleeding. Tranexamic acid stops the breakdown of these clots and thus reduces bleeding.

This medicine is used to prevent or reduce bleeding for a short period of time in many different conditions. You may have been prescribed it for one of the following:

  • After prostate surgery (post-prostatectomy).
  • After bladder surgery.
  • Heavy menstrual bleeding (menorrhagia).
  • Severe nosebleeds (severe epistaxis).
  • Cervical surgery (conization of the cervix).
  • To prevent repeated bleeding inside the eye (prevention of recurrent hemorrhage in traumatic hyphema).
  • Dental extraction in hemophiliacs (people who bleed more easily than normal). If this applies to you, you will know.
  • A hereditary disease called hereditary angioedema (HAE). Your doctor will inform you if you have this disease.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Zentiva Tranexamic Acid

Do not take Zentiva Tranexamic Acid:

  • If you are allergic to tranexamic acid or any of the other ingredients of this medicine (listed in section 6).
  • If you have severe kidney problems (renal insufficiency).
  • If you have or have had a blood clot in the blood vessels (i.e., thrombosis).
  • If you have a history of seizures.
  • If you are at risk of excessive bleeding due to a coagulation disorder called consumption coagulopathy.

If you are in any of the above situations, consult your doctor or pharmacist.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Zentiva Tranexamic Acid in the following cases:

  • If you have had seizures.
  • If you have visual impairment or blurred vision. Regular eye exams may be necessary, especially in the case of retinal diseases.
  • If you have had blood in your urine, which can cause a blockage of the urinary tract.
  • If you are at risk of having blood clots. The risk of blood clotting events may increase in patients using oral contraceptives.
  • If you have hereditary angioedema, a hereditary disorder that causes inflammation of the deeper layers of the skin due to fluid accumulation.
  • If you have disseminated intravascular coagulation (DIC), a disease in which the blood begins to clot throughout the body.
  • If you are a woman with irregular periods.
  • If you have any kidney disease.

Other medicines and Zentiva Tranexamic Acid

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, in particular the following:

  • Fibrinolytic medicines (used to help break down blood clots), such as streptokinase. This is because Zentiva Tranexamic Acid would counteract the effect of these medicines.
  • Oral contraceptives. They may increase the risk of blood clot formation.
  • Any other medicine, including those that do not require a prescription.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using Zentiva Tranexamic Acid.

Tranexamic acid is excreted in breast milk, although in a minimal amount. If you are breastfeeding, consult your doctor or pharmacist before taking Zentiva Tranexamic Acid.

Zentiva Tranexamic Acid contains castor oil and sodium

Zentiva Tranexamic Acid contains castor oil. Castor oil may cause stomach upset and diarrhea.

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially "sodium-free".

3. How to take Zentiva Tranexamic Acid

Follow exactly the administration instructions of this medicine indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

Important:

Your doctor will choose the right dose for you. Your dose will be clearly stated on the doctor's prescription. If not, or if you have any doubts, ask your doctor or pharmacist.

Remember: This medicine should always be taken with a glass of water. The tablets should be swallowed whole. Do not crush or chew them.

Use in adults and elderly patients

  • The usual dose is 2 or 3 tablets 2 to 3 times a day.
  • The exact dose for you depends on the reason why you have been prescribed this medicine.
  • Follow your doctor's instructions about how many tablets you should take, when you should take them, and the duration of treatment.

Use in children

Your doctor will tell you exactly what dose to give to the child. Your doctor will calculate the dose based on the child's weight.

Patients with kidney problems

Your doctor will tell you what dose to take. The dose you take may be lower than the usual dose for adults.

If you take more Zentiva Tranexamic Acid than you should

If you take too much Zentiva Tranexamic Acid, you may feel nauseous or vomit or feel dizzy or faint when standing up.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.

If you forget to take Zentiva Tranexamic Acid

Do not take a double dose to make up for a forgotten dose. Simply take the next dose as planned.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor immediately if you experience any of the following:

  • hypersensitivity reactions, such as a severe and sudden allergic reaction that causes difficulty breathing or dizziness (anaphylaxis)

Rare (affect 1 to 10 people in every 1,000)

  • Visual disturbances, especially in color vision.
    • Formation of a blood clot in an eye. This can cause bleeding in the eye or vision loss.
    • Itching, redness, or swelling of the skin.

Very rare (affect less than 1 person in every 10,000)

  • Formation of a blood clot in the blood vessels (i.e., thrombosis).
  • Allergic reactions that can cause difficulty breathing or dizziness.
  • Nausea.
  • Vomiting.
  • Diarrhea.
  • Seizures or convulsions.
  • General feeling of discomfort (malaise) and low blood pressure (hypotension), with or without loss of consciousness.

Nausea, vomiting, and diarrhea are usually mild and disappear quickly; but if they continue, inform your doctor or pharmacist.

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report side effects directly through the national reporting system included in the Spanish Medicines Surveillance System for Human Use: www.notificaRAM.es By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Zentiva Tranexamic Acid

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the packaging. The expiry date is the last day of the month indicated.

This medicine does not require any special storage conditions.

It should be used within 25 days after first opening the plastic bottle (HDPE).

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Zentiva Tranexamic Acid

The active substance is tranexamic acid. Each tablet contains 500 mg of tranexamic acid.

The other ingredients are microcrystalline cellulose, pregelatinized corn starch, low-substituted hydroxypropylcellulose, anhydrous colloidal silica, povidone, talc, hydrogenated castor oil, magnesium stearate, hypromellose, titanium dioxide, macrogol, propylene glycol, and sodium lauryl sulfate.

This medicine contains 5.50% (w/w) propylene glycol as a necessary component for the medicine to work properly.

Appearance of the product and pack contents

Zentiva Tranexamic Acid tablets are white to pale yellow in color, oval in shape, and film-coated, smooth on both sides, for oral use.

Zentiva Tranexamic Acid is available in:

Blister packs (OPA/Alu/PVC) containing 10, 20, 30, 50, 60, and 100 tablets.

High-density polyethylene (HDPE) bottles containing 100 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Zentiva, k.s.,

U kabelovny 130,

Prague 10 – Dolní Mecholupy,

102 37 Czech Republic

Manufacturer[1]

MIAS Pharma Limited

Suite 2, Stafford House, Strand Road

Portmarnock, Co. Dublin

Ireland

Tillomed Malta Limited,

Malta Life Sciences Park,

LS2.01.06 Industrial Estate,

San Gwann, SGN 3000, Malta

SGS Pharma Magyarorszag Kft.

Derkovits Gyula Utca 53,

Budapest XIX,1193,

Hungary

[1] Only the site that actually performs the release will be indicated on the marketed product.

You can obtain further information on this medicine from the local representative of the marketing authorization holder:

Zentiva Spain S.L.U.,

Avenida de Europa, 19, Edificio 3, Planta 1.

28224 Pozuelo de Alarcón, Madrid

Spain

This medicine is authorized in the Member States of the European Economic Area under the following names:

Austria Tranexamsäure Tillomed 500 mg Filmtabletten

Germany Tranexamsäure Tillomed 500 mg Filmtabletten

Spain Ácido tranexámico Zentiva 500 mg film-coated tablets EFG

Netherlands Tranexaminezuur Tillomed 500 mg filmomhulde tabletten

Poland Tranexamic Acid Tillomed

Date of last approval of this leaflet: September 2023.

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es /

[1]

Online doctors for TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS

Discuss questions about TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS?
TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS?
The active ingredient in TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS is tranexamic acid. This information helps identify medicines with the same composition but different brand names.
How much does TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS cost in pharmacies?
The average pharmacy price for TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS is around 4.62 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS?
TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS is manufactured by Zentiva K.S.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to TRANEXAMIC ACID ZENTIVA 500 mg FILM-COATED TABLETS?
Other medicines with the same active substance (tranexamic acid) include TRANEXAMIC ACID APC INSTYTUT 500 mg FILM-COATED TABLETS, TRANEXAMIC ACID BAXTER 100 mg/mL INJECTABLE SOLUTION, AMCHAFIBRIN 500 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media